Importantly, PLG nanoparticle treatment significantly reduced α-SMA expression in SSc, but not in healthy control fibroblasts, despite comparable nanoparticle uptake (Figure 7, F and G). This evidence concerns the gene ACTA1 and systemic sclerosis.